🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
The purpose of this study is to show that subcutaneous (SC) administration ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-10-27
Trial ID
NCT03277105
The purpose of this study is to evaluate the tolerability and safety of sub...
Status
Completed
Location
National Hospital Organization Shibukawa Medical Center
Start Date
2017-08-10
Trial ID
NCT03242889
Treatments Being Tested
Achievement of complete hematologic response (CHR) is vital for systemic AL...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2024-01-05
Trial ID
NCT06192979
Treatments Being Tested
The purpose of this study is to investigate whether teclistamab-daratumumab...
Status
Recruiting
Location
Boston Medical Center
Start Date
2025-11-07
Trial ID
NCT07110844
Treatments Being Tested
This trial will study how safely the tazemetostat works with other therapie...
Status
Withdrawn
Location
California Cancer Associates For Research And Excellence, cCARE
Start Date
2021-12-22
Trial ID
NCT05205252
This phase II trial tests daratumumab given at a reduced frequency with len...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2026-04-20
Trial ID
NCT07485647
Treatments Being Tested
This is a prospective and single arm clinical study. The goal of this clini...
Status
Unknown
Location
The First Affiliated Hospital of Wenzhou Medical University
Start Date
2024-03-01
Trial ID
NCT06455748
Treatments Being Tested
TAK-981 is being tested in combination with anti-CD38 monoclonal antibodies...
Status
Terminated
Location
Mayo Clinic Arizona - PPDS
Start Date
2021-04-20
Trial ID
NCT04776018
Treatments Being Tested
This phase I trial studies the possible benefits and side effects of adding...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2021-09-27
Trial ID
NCT04956302
Treatments Being Tested